These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38913598)

  • 1. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting
    Gohar NA; Fayed EA; A Ammar Y; A Abu Ali O; Ragab A; Mahfoz AM; Abusaif MS
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2367128. PubMed ID: 38913598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.
    Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A
    Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-γ Agonists, α-Glucosidase, α-Amylase and COX-2 inhibitors; Design, synthesis and in silico study.
    Fadaly WAA; Elshewy A; Nemr MTM; Abdou K; Sayed AM; Kahk NM
    Bioorg Chem; 2024 Nov; 152():107760. PubMed ID: 39197383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
    Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
    Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile synthesis and
    Punia R; Mor S; Khatri M; Kumar D; Das PP; Jindal DK; Kumar A; Selvaraj P; Kumar R; Mohil R; Jakhar K
    Future Med Chem; 2024; 16(10):999-1027. PubMed ID: 38910576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation.
    Ragab A; Salem MA; Ammar YA; Aboulthana WM; Helal MH; Abusaif MS
    Drug Dev Res; 2024 Jun; 85(4):e22216. PubMed ID: 38831547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes.
    Alasmary FAS; Abdullah DA; Masand VH; Ben Bacha A; Omar Ebeid AM; El-Araby ME; Alafeefy AM
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2395985. PubMed ID: 39311475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
    Kothari M; Kannan K; Sahadevan R; Sadhukhan S
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel acyl hydrazide derivatives of polyhydroquinoline as potent anti-diabetic and anti-glycating agents: Synthesis, in vitro α-amylase, α-glucosidase inhibition and anti-glycating activity with molecular docking insights.
    Ur Rahman S; Alam A; Parveen Z; Zainab ; Assad M; Adnan Ali Shah S; Rafiq H; Ayaz M; Latif A; Naveed Umar M; Ali M; Ahmad M
    Bioorg Chem; 2024 Sep; 150():107501. PubMed ID: 38865858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
    Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
    Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation.
    Luo S; Zhao L; Peng H; Peng Z; Wang G
    Eur J Med Chem; 2024 Sep; 275():116600. PubMed ID: 38889608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of obovatol and related neolignan analogues as α-glucosidase and α-amylase inhibitors.
    Sciacca C; Cardullo N; Pulvirenti L; Travagliante G; D'Urso A; D'Agata R; Peri E; Cancemi P; Cornu A; Deffieux D; Pouységu L; Quideau S; Muccilli V
    Bioorg Chem; 2024 Jun; 147():107392. PubMed ID: 38723423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors.
    Kazmi M; Zaib S; Amjad ST; Khan I; Ibrar A; Saeed A; Iqbal J
    Bioorg Chem; 2017 Oct; 74():134-144. PubMed ID: 28780150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
    Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
    Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities.
    Hameed S; Khan KM; Salar U; Özil M; Baltaş N; Saleem F; Qureshi U; Taha M; Ul-Haq Z
    Int J Biol Macromol; 2022 Nov; 221():1294-1312. PubMed ID: 36113601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
    Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
    Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spiroindolone Analogues as Potential Hypoglycemic with Dual Inhibitory Activity on α-Amylase and α-Glucosidase.
    Altowyan MS; Barakat A; Al-Majid AM; Al-Ghulikah HA
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31242688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
    Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
    Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.